CS2164 combined with radiation suppressed tumor growth via γ-H2AX persistence and ROS accumulation
Abstract Background CS2164 is an oral multi-target inhibitor that targets angiogenesis-related kinases, mitosis-related kinases, and chronic inflammation-related kinases. However, the added clinical benefit of CS2164 combined with radiation remains unknown. Methods The anti-tumor effect of CS2164 co...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2026-03-01
|
| סדרה: | BMC Cancer |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12885-026-15865-y |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
